GlassScriptPhysician profile
Shiny Jacob
NPI 1235586892
$2,404.62
in general payments reported to CMS, 2019-2025
20 companies · $1,089 in 2025
The $1,089 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $101 · 2023: $388 · 2024: $709 · 2025: $1,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $621.31 | 2022-2025 | Aurora Ev-Icd Mri Surescan, Cobalt Dr Mri Surescan, Micra |
| Atricure, INC. | $330.04 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Isolator Surgical Ablation System |
| Abbott Laboratories | $284.56 | 2021-2025 | Aveir, Amplatzer Amulet, Confirm Rx |
| Boston Scientific Corporation | $244.31 | 2023-2025 | Farapulse, Watchman Flx, Watchman Access System |
| Djo, LLC | $146.64 | 2024 | Procare |
| Biosense Webster, INC. | $139.65 | 2021-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $125.67 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $90.06 | 2025 | Rexulti |
| Neurocrine Biosciences, INC. | $85.86 | 2025 | |
| Cardiva Medical, INC. | $65.09 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $62.29 | 2025 | Caplyta |
| Edwards Lifesciences Corporation | $33.74 | 2023 | Hemosphere |
| Bayer Healthcare Pharmaceuticals INC. | $30.49 | 2025 | |
| Lilly USA, LLC | $25.85 | 2024 | Zepbound |
| Medicomp INC | $23.22 | 2025 | Telepatch Cardiac Monitor |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.80 | 2025 | |
| Becton, Dickinson and Company | $20.11 | 2024 | Hemosphere |
| Lundbeck LLC | $19.36 | 2025 | Rexulti |
| Almatica Pharma LLC | $17.52 | 2024 | Loreev Xr |
| Astrazeneca Pharmaceuticals LP | $16.05 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiny Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.